Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The complement membrane attack complex (MAC), also known as the C5b-9 complex, is a multi-protein structure formed during the terminal phase of complement activation. It is a critical effector mechanism of innate immunity, responsible for directly lysing target cells such as bacteria by forming transmembrane pores that disrupt cellular integrity. Dysregulation or excessive formation can contribute to tissue injury in autoimmune diseases.
Pore formation leading to osmotic lysis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement Components C5b-9 Membrane Attack Complex (MAC).